X
CONTACT US

CONTACT US

Please complete this short form to get in touch with a member of our team and we will get back to you as soon as we can.

X
NEWSLETTER

NEWSLETTER

Sign up to our newsletter by completing the form below.

We use cookies.

To make your experience the best it can be, we use cookies and similar technologies on our site. We need your permission to allow these technologies, which will maximise browsing experience. For more information on how we use cookies and how to change your cookie settings, please see our cookies and privacy policy.

Header image for the current page Supporting the life sciences industry to embed new technologies that help the prevention of atrial fibrillation strokes

Supporting the life sciences industry to embed new technologies that help the prevention of atrial fibrillation strokes

Share this page

Experts within our Life Science Hub were sponsored by the BMS-Pfizer Alliance to create an Atrial Fibrillation digital toolkit, allowing NHS commissioners to identify impactful treatments and interventions in their area.

Andi Orlowski and Wayne Smith, of the Health Economics Unit, used published data of primary care performance, QOF targets and prevalence estimates to identify optimal goals for AF management, and helped to create realistic business plans for treating the condition. They created a digital tool which CCGs could use with their own local data, to identify gaps in services and calculate their potential costs.

As part of an online AF Toolkit, the work:

More than 25 new partnerships were established to support the AF stroke-prevention programme.

Read more about our Life Science Hub.